Theravance Biopharma (TBPH) CFO Sawaf Aziz Withholds 8,112 Shares for Taxes

What Happened

• Sawaf Aziz, Chief Financial Officer of Theravance Biopharma (TBPH), had 8,112 shares withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding was recorded at $16.95 per share for a total value of $137,498. This was a tax-withholding transaction (code F), not an open-market sale.

Key Details

• Transaction date: 2026-08-20; Filing date: 2026-08-24 (filed four days after the transaction; Form 4s are generally due within two business days, so this appears later than typical).
• Shares withheld: 8,112 at $16.95 per share; total value reported $137,498.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: Shares were withheld by the issuer to satisfy tax liabilities from RSU vesting; no open-market trade occurred.

Context

• This was a routine tax-withholding event tied to RSU vesting, not a directional buy or sell in the public market. Such withholdings are common and generally do not signal insider sentiment about the stock.
• For retail investors: purchases (buys) typically carry clearer signals than routine withholding or tax-related dispositions.